The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Parkinson's disease age at onset genome‐wide association study: Defining heritability, genetic loci, and α‐synuclein mechanisms
Open accessAbstract
Background: Increasing evidence supports an extensive and complex genetic contribution to PD. Previous genome‐wide association studies (GWAS) have shed light on the genetic basis of risk for this disease. However, the genetic determinants of PD age at onset are largely unknown. Objectives: To identify the genetic determinants of PD age at onset. Methods: Using genetic data of 28,568 PD cases, we performed a genome‐wide association study based on PD age at onset. Results: We estimated that the heritability of PD age at onset attributed to common genetic variation was ∼0.11, lower than the overall heritability of risk for PD (∼0.27), likely, in part, because of the subjective nature of this measure. We found two genome‐wide significant association signals, one at SNCA and the other a protein‐coding variant in TMEM175 , both of which are known PD risk loci and a Bonferroni‐corrected significant effect at other known PD risk loci, GBA , INPP5F/BAG3, FAM47E/SCARB2 , and MCCC1 . Notably, SNCA, TMEM175, SCARB2, BAG3 , and GBA have all been shown to be implicated in α‐synuclein aggregation pathways. Remarkably, other well‐established PD risk loci, such as GCH1 and MAPT , did not show a significant effect on age at onset of PD. Conclusions: Overall, we have performed the largest age at onset of PD genome‐wide association studies to date, and our results show that not all PD risk loci influence age at onset with significant differences between risk alleles for age at onset. This provides a compelling picture, both within the context of functional characterization of disease‐linked genetic variability and in defining differences between risk alleles for age at onset, or frank risk for disease. © 2019 International Parkinson and Movement Disorder Society
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A global reference for human genetic variation
The 1000 Genomes Project Consortium, authors, C., Auton, A., Abecasis, G. R., Steering committee, Altshuler, D. M., Durbin, R. M., Abecasis, G. R., Bentley, D. R., Chakravarti, A., et al. (2015) · Nature · doi:10.1038/nature15393 · Cited by 18,247
Second-generation PLINK: rising to the challenge of larger and richer datasets
Chang, C. C., Chow, C. C., Tellier, L. C., Vattikuti, S., Purcell, S. M., & Lee, J. J. (2015) · Gigascience · doi:10.1186/s13742-015-0047-8 · Cited by 12,709
GCTA: a tool for genome-wide complex trait analysis
Yang, J., Lee, S. H., Goddard, M. E., & Visscher, P. M. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.11.011 · Cited by 8,279
Self-citationMutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
LD Score regression distinguishes confounding from polygenicity in genome-wide association studies
Schizophrenia Working Group of the Psychiatric Genomics Consortium, Bulik-Sullivan, B. K., Loh, P.-R., Finucane, H. K., Ripke, S., Yang, J., Patterson, N., Daly, M. J., Price, A. L., & Neale, B. M. (2015) · Nature Genetics · doi:10.1038/ng.3211 · Cited by 5,559
METAL: fast and efficient meta-analysis of genomewide association scans
Willer, C. J., Li, Y., & Abecasis, G. R. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq340 · Cited by 5,205
α-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
Self-citationFunctional mapping and annotation of genetic associations with FUMA
Watanabe, K., Taskesen, E., van Bochoven, A., & Posthuma, D. (2017) · Nature Communications · doi:10.1038/s41467-017-01261-5 · Cited by 4,083
Next-generation genotype imputation service and methods
Das, S., Forer, L., Schönherr, S., Sidore, C., Locke, A. E., Kwong, A., Vrieze, S. I., Chew, E. Y., Levy, S., McGue, M., et al. (2016) · Nature Genetics · doi:10.1038/ng.3656 · Cited by 3,808
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
Liu, C.-C., Kanekiyo, T., Xu, H., & Bu, G. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.263 · Cited by 3,459
Browning, S. R., & Browning, B. L. (2007) · The American Journal of Human Genetics · doi:10.1086/521987 · Cited by 3,210
A reference panel of 64,976 haplotypes for genotype imputation
the Haplotype Reference Consortium (2016) · Nature Genetics · doi:10.1038/ng.3643 · Cited by 2,836
LocusZoom: regional visualization of genome-wide association scan results
Pruim, R. J., Welch, R. P., Sanna, S., Teslovich, T. M., Chines, P. S., Gliedt, T. P., Boehnke, M., Abecasis, G. R., & Willer, C. J. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq419 · Cited by 2,707
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
Sidransky, E., Nalls, M. A., Aasly, J. O., Aharon-Peretz, J., Annesi, G., Barbosa, E. R., Bar-Shira, A., Berg, D., Bras, J., Brice, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901281 · Cited by 2,135
Self-citationInternational Parkinson's Disease Genomics Consortium (IPDGC), Nalls, M. A., Parkinson's Study Group (PSG) Parkinson's Research: The Organized GENetics Initiative (PROGENI), 23andMe, GenePD, NeuroGenetics Research Consortium (NGRC), Hussman Institute of Human Genomics (HIHG), Investigator, T. A. J. D., (CHARGE), C. F. H. A. A. R. I. G. E., North American Brain Expression Consortium (NABEC), et al. (2014) · Nature Genetics · doi:10.1038/ng.3043 · Cited by 1,895
Self-citationCalculating statistical power in Mendelian randomization studies.
Brion, M.-J. A., Shakhbazov, K., & Visscher, P. M. (2013) · International Journal of Epidemiology · doi:10.1093/ije/dyt179 · Cited by 1,751
Self-citationGenome-wide association study reveals genetic risk underlying Parkinson's disease
Simón-Sánchez, J., Schulte, C., Bras, J. M., Sharma, M., Gibbs, J. R., Berg, D., Paisan-Ruiz, C., Lichtner, P., Scholz, S. W., Hernandez, D. G., et al. (2009) · Nature Genetics · doi:10.1038/ng.487 · Cited by 1,751
Self-citationReference-based phasing using the Haplotype Reference Consortium panel
Loh, P.-R., Danecek, P., Palamara, P. F., Fuchsberger, C., A Reshef, Y., K Finucane, H., Schoenherr, S., Forer, L., McCarthy, S., Abecasis, G. R., et al. (2016) · Nature Genetics · doi:10.1038/ng.3679 · Cited by 1,723
Genetic Investigation of ANthropometric Traits (GIANT) Consortium, Yang, J., DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium, Ferreira, T., Morris, A. P., Medland, S. E., Madden, P. A. F., Heath, A. C., Martin, N. G., Montgomery, G. W., et al. (2012) · Nature Genetics · doi:10.1038/ng.2213 · Cited by 1,712
Self-citationMazzulli, J. R., Xu, Y.-H., Sun, Y., Knight, A. L., McLean, P. J., Caldwell, G. A., Sidransky, E., Grabowski, G. A., & Krainc, D. (2011) · Cell · doi:10.1016/j.cell.2011.06.001 · Cited by 1,341
A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci
Chang, D., Nalls, M. A., Hallgrímsdóttir, I. B., Hunkapiller, J., van der Brug, M., Cai, F., International Parkinson's Disease Genomics Consortium, 23andMe Research Team, Kerchner, G. A., Ayalon, G., et al. (2017) · Nature Genetics · doi:10.1038/ng.3955 · Cited by 1,112
Self-citationThe Parkinson Pandemic—A Call to Action
Dorsey, E. R., & Bloem, B. R. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2017.3299 · Cited by 1,091
Ageing and Parkinson's disease: Why is advancing age the biggest risk factor?
Reeve, A., Simcox, E., & Turnbull, D. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.01.004 · Cited by 947
Hyde, C. L., Nagle, M. W., Tian, C., Chen, X., Paciga, S. A., Wendland, J. R., Tung, J. Y., Hinds, D. A., Perlis, R. H., & Winslow, A. R. (2016) · Nature Genetics · doi:10.1038/ng.3623 · Cited by 784
Self-citationGender differences in Parkinson's disease
Haaxma, C. A., Bloem, B. R., Borm, G. F., Oyen, W. J. G., Leenders, K. L., Eshuis, S., Booij, J., Dluzen, D. E., & Horstink, M. W. I. M. (2007) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.103788 · Cited by 741
minimac2: faster genotype imputation
Fuchsberger, C., Abecasis, G. R., & Hinds, D. A. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btu704 · Cited by 651
Self-citationStatistical power and significance testing in large-scale genetic studies
Sham, P. C., & Purcell, S. M. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3706 · Cited by 573
Parkinson-associated risk variant in distal enhancer of α-synuclein modulates target gene expression
Soldner, F., Stelzer, Y., Shivalila, C. S., Abraham, B. J., Latourelle, J. C., Barrasa, M. I., Goldmann, J., Myers, R. H., Young, R. A., & Jaenisch, R. (2016) · Nature · doi:10.1038/nature17939 · Cited by 500
Web-Based, Participant-Driven Studies Yield Novel Genetic Associations for Common Traits
Eriksson, N., Macpherson, J. M., Tung, J. Y., Hon, L. S., Naughton, B., Saxonov, S., Avey, L., Wojcicki, A., Pe'er, I., & Mountain, J. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000993 · Cited by 479
Lo, M.-T., Hinds, D. A., Tung, J. Y., Franz, C., Fan, C.-C., Wang, Y., Smeland, O. B., Schork, A., Holland, D., Kauppi, K., et al. (2017) · Nature Genetics · doi:10.1038/ng.3736 · Cited by 440
Self-citationZhan, X., Hu, Y., Li, B., Abecasis, G. R., & Liu, D. J. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btw079 · Cited by 396
Differential effects of severe vs mild GBA mutations on Parkinson disease
Gan-Or, Z., Amshalom, I., Kilarski, L. L., Bar-Shira, A., Gana-Weisz, M., Mirelman, A., Marder, K., Bressman, S., Giladi, N., & Orr-Urtreger, A. (2015) · Neurology · doi:10.1212/wnl.0000000000001315 · Cited by 364
Self-citationGenotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset
Gan-Or, Z., Giladi, N., Rozovski, U., Shifrin, C., Rosner, S., Gurevich, T., Bar-Shira, A., & Orr-Urtreger, A. (2008) · Neurology · doi:10.1212/01.wnl.0000304039.11891.29 · Cited by 360
Self-citationGenomic investigation of α‐synuclein multiplication and parkinsonism
Ross, O. A., Braithwaite, A. T., Skipper, L. M., Kachergus, J., Hulihan, M. M., Middleton, F. A., Nishioka, K., Fuchs, J., Gasser, T., Maraganore, D. M., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21380 · Cited by 342
Self-citationGWAS of Longevity in CHARGE Consortium Confirms APOE and FOXO3 Candidacy
Broer, L., Buchman, A. S., Deelen, J., Evans, D. S., Faul, J. D., Lunetta, K. L., Sebastiani, P., Smith, J. A., Smith, A. V., Tanaka, T., et al. (2015) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glu166 · Cited by 277
Self-citationIncidence of Parkinson's disease in Norway: the Norwegian ParkWest study
Alves, G., Muller, B., Herlofson, K., HogenEsch, I., Telstad, W., Aarsland, D., Tysnes, O.-B., Larsen, J. P., & for the Norwegian ParkWest study group (2009) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.168211 · Cited by 273
Guerreiro, R., Ross, O. A., Kun-Rodrigues, C., Hernandez, D. G., Orme, T., Eicher, J. D., Shepherd, C. E., Parkkinen, L., Darwent, L., Heckman, M. G., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30400-3 · Cited by 270
Self-citationMUTATIONS IN GBA ARE ASSOCIATED WITH FAMILIAL PARKINSON DISEASE SUSCEPTIBILITY AND AGE AT ONSET
Sidransky, E., Samaddar, T., & Tayebi, N. (2009) · Neurology · doi:10.1212/wnl.0b013e3181b28601 · Cited by 259
Parkinson disease male-to-female ratios increase with age: French nationwide study and meta-analysis
Moisan, F., Kab, S., Mohamed, F., Canonico, M., Le Guern, M., Quintin, C., Carcaillon, L., Nicolau, J., Duport, N., Singh-Manoux, A., et al. (2016) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2015-312283 · Cited by 244
Jinn, S., Drolet, R. E., Cramer, P. E., Wong, A. H.-K., Toolan, D. M., Gretzula, C. A., Voleti, B., Vassileva, G., Disa, J., Tadin-Strapps, M., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1616332114 · Cited by 243
Autosomal dominant Parkinson's disease caused by SNCA duplications
Konno, T., Ross, O. A., Puschmann, A., Dickson, D. W., & Wszolek, Z. K. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.09.007 · Cited by 210
Cryptic Distant Relatives Are Common in Both Isolated and Cosmopolitan Genetic Samples
Henn, B. M., Hon, L., Macpherson, J. M., Eriksson, N., Saxonov, S., Pe'er, I., & Mountain, J. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034267 · Cited by 204
Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset
Nichols, W. C., Pankratz, N., Marek, D. K., Pauciulo, M. W., Elsaesser, V. E., Halter, C. A., Rudolph, A., Wojcieszek, J., Pfeiffer, R. F., & Foroud, T. (2009) · Neurology · doi:10.1212/01.wnl.0000327823.81237.d1 · Cited by 202
Using genome-wide complex trait analysis to quantify ‘missing heritability’ in Parkinson’s disease
Keller, M. F., Saad, M., Bras, J., Bettella, F., Nicolaou, N., Simon-Sanchez, J., Mittag, F., Buchel, F., Sharma, M., Gibbs, J. R., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds335 · Cited by 190
Self-citationGlucocerebrosidase depletion enhances cell-to-cell transmission of α-synuclein
Bae, E.-J., Yang, N.-Y., Song, M., Lee, C. S., Lee, J. S., Jung, B. C., Lee, H.-J., Kim, S., Masliah, E., Sardi, S. P., et al. (2014) · Nature Communications · doi:10.1038/ncomms5755 · Cited by 177
Age-specific penetrance of LRRK2 G2019S in the Michael J. Fox Ashkenazi Jewish LRRK2 Consortium
Marder, K., Wang, Y., Alcalay, R. N., Mejia-Santana, H., Tang, M.-X., Lee, A., Raymond, D., Mirelman, A., Saunders-Pullman, R., Clark, L., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001708 · Cited by 161
Worldwide frequency of G2019S LRRK2 mutation in Parkinson's disease: A systematic review
Correia Guedes, L., Ferreira, J. J., Rosa, M. M., Coelho, M., Bonifati, V., & Sampaio, C. (2010) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2009.11.004 · Cited by 161
Penetrance estimate of LRRK2 p.G2019S mutation in individuals of non‐Ashkenazi Jewish ancestry
Lee, A. J., Wang, Y., Alcalay, R. N., Mejia‐Santana, H., Saunders‐Pullman, R., Bressman, S., Corvol, J., Brice, A., Lesage, S., Mangone, G., et al. (2017) · Movement Disorders · doi:10.1002/mds.27059 · Cited by 161
Self-citationPolygenic risk of P arkinson disease is correlated with disease age at onset
Escott‐Price, V., Nalls, M. A., Morris, H. R., Lubbe, S. J., Brice, A., Gasser, T., Heutink, P., Wood, N. W., Hardy, J., Singleton, A., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24335 · Cited by 143
Self-citationFeatures of GBA-associated Parkinson’s disease at presentation in the UK Tracking Parkinson’s study
Malek, N., Weil, R. S., Bresner, C., Lawton, M., Grosset, K. A., Tan, M. M. X., Bajaj, N. P. S., Barker, R. A., Burn, D. J., Foltynie, T., et al. (2018) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2017-317348 · Cited by 136
Self-citationDu, T., Wang, L., Duan, C., Lu, L., Zhang, J., Gao, G., Qiu, X., Wang, X., & Yang, H. (2015) · Autophagy · doi:10.1080/15548627.2015.1086055 · Cited by 132
LIMP-2 expression is critical for β-glucocerebrosidase activity and α-synuclein clearance
Rothaug, M., Zunke, F., Mazzulli, J. R., Schweizer, M., Altmeppen, H. C., Lüllmann‐Rauch, R., Kallemeijn, W. W., Gaspar, P., Aerts, J. M. F. G., Glatzel, M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1405700111 · Cited by 125
Genomewide association study for onset age in Parkinson disease
Latourelle, J. C., Pankratz, N., Dumitriu, A., Wilk, J. B., Goldwurm, S., Pezzoli, G., Mariani, C. B., DeStefano, A. L., Halter, C. A., Gusella, J. F., et al. (2009) · BMC Medical Genetics · doi:10.1186/1471-2350-10-98 · Cited by 124
A large study reveals no association between APOE and Parkinson's disease
Federoff, M., Jimenez‐Rolando, B., Nalls, M. A., & Singleton, A. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.02.002 · Cited by 110
Self-citationVariants in GBA , SNCA , and MAPT influence Parkinson disease risk, age at onset, and progression
Davis, A. A., Andruska, K. M., Benítez, B. A., Racette, B. A., Perlmutter, J. S., & Cruchaga, C. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.09.014 · Cited by 107
The Evolution of Genetics: Alzheimer’s and Parkinson’s Diseases
Singleton, A., & Hardy, J. (2016) · Neuron · doi:10.1016/j.neuron.2016.05.040 · Cited by 94
Self-citationApoE gene and exceptional longevity: Insights from three independent cohorts
Garatachea, N., Emanuele, E., Calero, M., Fuku, N., Arai, Y., Abe, Y., Murakami, H., Miyachi, M., Yvert, T., Verde, Z., et al. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2014.02.004 · Cited by 84
Hamza, T. H., & Payami, H. (2010) · Journal of Human Genetics · doi:10.1038/jhg.2010.13 · Cited by 80
Impact of Parkinson's disease risk loci on age at onset
Lill, C. M., Hansen, J., Olsen, J. H., Binder, H., Ritz, B. R., & Bertram, L. (2015) · Movement Disorders · doi:10.1002/mds.26237 · Cited by 76
Genetic risk and age in Parkinson's disease: Continuum not stratum
Nalls, M. A., Escott‐Price, V., Williams, N. M., Lubbe, S. J., Keller, M. F., Morris, H. R., & Singleton, A. (2015) · Movement Disorders · doi:10.1002/mds.26192 · Cited by 76
Self-citationDumitriu, A., Pacheco, C. D., Wilk, J. B., Strathearn, K. E., Latourelle, J. C., Goldwurm, S., Pezzoli, G., Rochet, J., Lindquist, S., & Myers, R. H. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr026 · Cited by 71
A role of BAG3 in regulating SNCA/α-synuclein clearance via selective macroautophagy
Cao, Y.-L., Yang, Y., Mao, C., Zhang, X., Wang, C.-T., Yang, H. J., Lv, D.-J., Wang, F., Hu, L., & Liu, C. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.08.023 · Cited by 64
A comprehensive analysis of SNCA ‐related genetic risk in sporadic parkinson disease
Pihlstrøm, L., Blauwendraat, C., Cappelletti, C., Berge‐Seidl, V., Langmyhr, M., Henriksen, S. P., van de Berg, W. D. J., Gibbs, J. R., Cookson, M. R., Singleton, A., et al. (2018) · Annals of Neurology · doi:10.1002/ana.25274 · Cited by 64
Self-citationIdentification of genetic modifiers of age-at-onset for familial Parkinson’s disease
Hill‐Burns, E. M., Ross, O. A., Wissemann, W. T., Soto‐Ortolaza, A. I., Zareparsi, S., Siuda, J. S., Lynch, T., Wszołek, Z. K., Silburn, P. A., Mellick, G. D., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw206 · Cited by 52
SNCA: Major genetic modifier of age at onset of Parkinson's disease
Brockmann, K., Schulte, C., Hauser, A., Lichtner, P., Huber, H., Maetzler, W., Berg, D., & Gasser, T. (2013) · Movement Disorders · doi:10.1002/mds.25469 · Cited by 48
Self-citationKlebe, S., Golmard, J., Nalls, M. A., Saad, M., Singleton, A., Brás, J., Hardy, J., Simón‐Sánchez, J., Heutink, P., Kuhlenbäumer, G., et al. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-304475 · Cited by 43
Self-citationZhou, K., Bellenguez, C., Sutherland, C. D., Hardie, D. G., Palmer, C., Donnelly, P., & Pearson, E. R. (2012) · Nature Genetics · doi:10.1038/ng.2234 · Cited by 41
Virtual research visits and direct-to-consumer genetic testing in Parkinson’s disease
Dorsey, E. R., Darwin, K. C., Mohammed, S., Donohue, S., Tethal, A., Achey, M. A., Ward, S., Caughey, E., Conley, E. D., Eriksson, N., et al. (2015) · Digital Health · doi:10.1177/2055207615592998 · Cited by 39
Association of LRRK2 Haplotype With Age at Onset in Parkinson Disease
Xiao, B., Deng, X., Ng, E. Y., Allen, J. C., Lim, S., Ahmad‐Annuar, A., & Tan, E. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2017.3363 · Cited by 23
Cited by
The genetic architecture of Parkinson's disease
Blauwendraat, C., Nalls, M. A., & Singleton, A. B. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30287-x · Cited by 1,114
Self-citationFerroptosis and its potential role in the physiopathology of Parkinson’s Disease
Mahoney-Sánchez, L., Bouchaoui, H., Ayton, S., Devos, D., Duce, J. A., & Devedjian, J.-C. (2021) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2020.101890 · Cited by 553
Parkinson disease and the immune system - Associations, mechanisms and therapeutics
Tan, E.-K., Chao, Y.-X., West, A., Chan, L.-L., Poewe, W., & Jankovic, J. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0344-4 · Cited by 457
Self-citationGenetics and Pathogenesis of Parkinson's Syndrome
Ye, H., Robak, L. A., Yu, M., Cykowski, M., & Shulman, J. M. (2023) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-031521-034145 · Cited by 416
Self-citationGenetics of Parkinson's disease: An introspection of its journey towards precision medicine
Bandres-Ciga, S., Diez-Fairen, M., Kim, J. J., & Singleton, A. B. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104782 · Cited by 370
Self-citation
Metadata
- Authors
- Blauwendraat, C., Heilbron, K., Vallerga, C. L., Bandres‐Ciga, S., von Coelln, R., Pihlstrøm, L., Simón‐Sánchez, J., Schulte, C., Sharma, M., Krohn, L., Siitonen, A., Iwaki, H., Leonard, H., Noyce, A. J., Tan, M., Gibbs, J. R., Hernandez, D. G., Scholz, S. W., Jankovic, J., Shulman, L. M., Lesage, S., Corvol, J., Brice, A., van Hilten, J. J., Marinus, J., The 23andMe Research Team, Eerola‐Rautio, J., Tienari, P., Majamaa, K., Toft, M., Grosset, D. G., Gasser, T., Heutink, P., Shulman, J. M., Wood, N., Hardy, J., Morris, H. R., Hinds, D. A., Gratten, J., Visscher, P. M., Gan‐Or, Z., Nalls, M. A., Singleton, A. B., & for the International Parkinson's Disease Genomics Consortium (IPDGC)
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2019-04-07
- Volume
- 34
- Issue
- 6
- Pages
- 866-875
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W2937319110
- Cited by
- 338
- References
- 69
- FWCI
- 29.00
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.